Navigation Links
Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
Date:8/6/2008

n allergic reaction before. If your healthcare professional tells you that you can take ZIAGEN again, start taking it when you are around medical help or people who can call a doctor if you need one.

A build up of lactic acid in the blood and an enlarged liver, including fatal cases, have been reported.

Do not take ZIAGEN if your liver does not function normally.

Worsening of liver disease (sometimes resulting in death) has occurred in patients infected with both HIV and hepatitis C virus who are taking anti-HIV medicines and are also being treated for hepatitis C with interferon with or without ribavirin. If you are taking ZIAGEN as well as interferon with or without ribavirin and you experience side effects, be sure to tell your doctor.

When you start taking HIV medicines, your immune system may get stronger and could begin to fight infections that have been hidden in your body, such as pneumonia, herpes virus, or tuberculosis. If you have new symptoms after starting your HIV medicines, be sure to tell your doctor.

Changes in body fat may occur in some patients taking antiretroviral therapy. These changes may include an increased amount of fat in the upper back and neck ("buffalo hump"), breast, and around the trunk. Loss of fat from the legs, arms, and face may also occur. The cause and long-term health effects of these conditions are not known at this time.

Some HIV medicines including ZIAGEN may increase your risk of heart attack. If you have heart problems, smoke, or suffer from diseases that increase your risk of heart disease such as high blood pressure, high cholesterol, or diabetes, tell your doctor.

The most common side effects of ZIAGEN include nausea, vomiting, tiredness, headache, diarrhea, trouble sleeping, fever and chills, and loss of appetite. Most of these side effects did not cause people to stop taking ZIAGEN.

For additional important information about ZIAGEN please visit

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Deutsche Bank Health Care Conference to be held ... Adrian Adams , Chief Executive Officer ... the Company and its product pipeline at 12:00 p.m. ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will ...
(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...
(Date:5/23/2013)... BRAINTREE, Mass. , May 23, 2013  Haemonetics Corporation ... Chris Lindop , CFO & EVP-Business Development, will present ... Care Conference in Boston, MA on ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may ... About Haemonetics Haemonetics (NYSE: ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 43SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
(Date:5/24/2013)... Alzheimer,s researchers failed to replicate what appeared to be ... when they were published last year in the journal ... 9, 2012, suggested that the drug bexarotene (marketed as ... plaques (Aβ) a pathological hallmark of Alzheimer,s disease ... authors of the 2012 report, drug treatment quickly removed ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Amirsys today ... exciting new enhancements for instructors and students. Instructors can ... focused through personalize learning plan templates, targeted reading assignments, ... provides 500 new assessment questions, 5,000 searchable anatomy glossary ... , AnatomyOne 2.0 is the first gross ...
(Date:5/24/2013)... CA (PRWEB) May 24, 2013 Mr. ... present the 3rd Annual EB-5 Investment Summit: Dealmakers Conference ... Dealmakers Conference will focus on exploring alternative finance through ... latest market, legal and economic information, and updates to ... within the EB-5 industry. , "Our goal is ...
(Date:5/24/2013)... 24, 2013 Dwell Media LLC ... Huff as Executive Vice President of Digital for Dwell ... which represented a large portion of Yahoo's global media ... Dwell develops a fully-integrated commerce unit to launch in ... monetizing digital content for leading firms in Silicon Valley. ...
(Date:5/24/2013)... 24, 2013 Mike Stoler believes that ... successful business people in New York. That’s why ... weekly on CUNY TV. And that’s why he ... Allergy Associates, LLP (ENTA)—the largest single specialty practice in ... throat, allergy and audiology specialists and sub-specialists service communities ...
Breaking Medicine News(10 mins):Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4
... transmitted by the tiny sand fly, has affected an estimated 25,000 ... The disease has got 31 of the state's 38 districts in ... it affects the poorest of the poor, the disease has affected ... Patna. Manjhi is desperate to earn more money to treat his ...
... park and a vaccine park in Chennai soon to help ... research into new vaccines, said Health Minister Anbumani Ramadoss. ... medical equipment for the country, the vaccine park will research ... medical park will be built on 300 acres of land ...
... their proteins go unfolded. It's a reaction with a ... ,Now, new research from Rockefeller University shows that ... a sign that the cell has given up, it ... with adversity. ,Diabetes, cancer, and neurodegenerative diseases ...
... new study that takes a rare look at the physiological, ... shows that when older adults go to bed lonely, sad ... waking the next morning. ,Elevated levels of cortisol ... health problems when chronic -- actually cue the body on ...
... has discovered a target site within malaria-carrying mosquitoes that ... to the Anopheles gambiae mosquito and other mosquito species. ... supported by further studies, the findings could offer a ... as malaria. , ,Yuan-Ping Pang, Ph.D., a ...
... a protein's role in the immune system have revealed ... in approximately one percent of all live births//. ... impairs the ureter’s ability to pump urine from the ... Ph.D., assistant professor of pathology and immunology. "If untreated, ...
Cached Medicine News:Health News:Kalaazar sweeping through Bihar, 93 dead 2Health News:India to set up medical and vaccine parks: Ramadoss 2Health News:Unfolded Proteins May Protect Cells from Dying 2Health News:Adults Who Go to Bed Lonely Get Stress Hormone Boost Next Morning 2Health News:Adults Who Go to Bed Lonely Get Stress Hormone Boost Next Morning 3Health News:Mayo Researcher Discovers Target Site for Developing Mosquito Pesticides 2Health News:Mayo Researcher Discovers Target Site for Developing Mosquito Pesticides 3Health News:Protein Essential for Kidney-to-Bladder Urine Transfer 2Health News:Protein Essential for Kidney-to-Bladder Urine Transfer 3
... rotary microtome, designed for fully motorized ... specimens, offers a broad application spectrum ... laboratory. This microtome meets the requirements ... fully motorized/electronic microtome for their laboratory. ...
... microtome with automatic fine/trim- feed system, ... precision cross roller bearings. For sectioning ... in biological, botany, and materials science. ... 90 mm can be accommodated. Performance, ...
... fixed and unfixed tissue in histology and neurology ... science The HM 650 V offers an ... 1,2 mm and frequency between 30 and 100 ... each other. All parameters can be set via ...
... Leica Microsystems offers a fully automated ... is designed to coverslip microscope glass ... smears. The instrument accepts quality-grade coverslips ... common mounting media. The capability of ...
Medicine Products: